Where can researchers source third-party tested MOTS-c?

Midwest Peptide supplies research-grade MOTS-c with a Certificate of Analysis included for every batch, validated by HPLC purity and mass spectrometry identity testing.

Age Verification

You must be 21 years or older to access this website. All products are for research use only.

Are you 21 years of age or older?

By entering, you confirm that you are at least 21 years old and agree to our terms of service.

Free shipping on every orderFree shipping on every order

5% off with Zelle or Apple CashSave an extra 5% when you pay with Zelle or Apple Cash

Bulk pricing discounts up to 18%Bulk pricing discounts up to 18% off

MOTS-c Cardioprotection Research | Midwest Peptide

MOTS-c Inflammation Research: AMPK Anti-Inflammatory EffectsPrev|DSIP Immune Research: Sleep-Immunity Interaction StudiesNext

MOTS-c Cardioprotection Research: Heart Injury Models

MOTS-c · Published April 24, 2026 · Updated May 18, 2026 · 7 min read

Quick Answer

MOTS-c cardioprotection research examines cardiac mitochondrial biology and heart injury models, including ischemia-reperfusion and oxidative damage protocols. Studies measure cardiac function, mitochondrial integrity, infarct size, and AMPK pathway activation across standardized cardioprotection research models. For research use only, not for human consumption.

MOTS-c Cardioprotection Research: Heart Injury Models

Research Use Only. All products are strictly for research use only (RUO). Not for human consumption. Products on this site are not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the FDA. By purchasing, you agree that you are a qualified researcher and that products will be used solely for in-vitro research purposes.

Cardiac Mitochondrial Biology
Ischemia Reperfusion Research
Metabolic Cardiomyopathy Research
Aging Cardiac Function
Heart Failure Model Research
Doxorubicin Cardiotoxicity
Cardiac Metabolism Under Treatment
Mitochondrial Quality Control
Research Peptide Referenced
Related Research Reading
Related Research Articles
Explore Related Products
Frequently Asked Questions
Glossary

MOTS-c cardioprotection research examines the protective effects of the mitochondrial derived peptide on cardiac tissue under ischemic, metabolic, and aging injury contexts. The MOTS-c research cluster documents the AMPK pathway activation, the exercise biology, and the aging research. This article extends the analysis into the cardiac compartment where the mitochondrial biology of MOTS-c is particularly relevant because the heart has among the highest mitochondrial density in the body.

Frequently Asked Questions

What is MOTS-c in research contexts?

MOTS-c is a 16-amino-acid mitochondrial-derived peptide encoded within the 12S rRNA region of mitochondrial DNA. It is studied in preclinical research as an exercise mimetic, an AMPK activator, and a regulator of metabolic homeostasis and aging biology.

How does MOTS-c affect cardiac mitochondrial function in research?

Cardiac tissue depends heavily on mitochondrial ATP production. MOTS-c research in heart injury models reports preserved mitochondrial function, reduced ROS production, maintained ATP synthesis capacity, and improved functional recovery after ischemic challenge.

What cardiac models are used in MOTS-c cardioprotection research?

Models include ischemia-reperfusion injury via coronary occlusion, doxorubicin-induced cardiotoxicity, hypertrophy and heart failure models, and aging-related cardiac decline studies. Endpoints span functional, biochemical, and histological measures.

Is MOTS-c approved for human use?

No. MOTS-c is not approved by the FDA for any human therapeutic use. It is supplied strictly for in-vitro and preclinical research purposes by qualified investigators.

Glossary

Key terms used in this article.

Mitochondrial-Derived Peptide (MDP): A class of small bioactive peptides encoded within the mitochondrial genome and translated within or near mitochondria.
AMPK: AMP-activated protein kinase, a cellular energy sensor activated under low ATP conditions to restore metabolic homeostasis.
Exercise Mimetic: A compound that produces molecular and physiological adaptations associated with physical exercise without requiring activity.
Mitochondrial Biogenesis: The cellular process of generating new mitochondria, regulated by PGC-1 alpha and other transcriptional coactivators.
Cardiomyocyte: A heart muscle cell, dependent on mitochondrial ATP production for continuous contraction.
Ischemia-Reperfusion: Tissue injury caused by restoration of blood flow following a period of ischemia, driven largely by oxidative stress.

More from the Blog

Continue exploring research insights and updates.

Subcutaneous vs Intranasal: Choosing an Administration Route for DSIP, Selank, and Kisspeptin in Research

Subcutaneous vs intranasal administration for CNS-targeted research peptides: how to choose between routes for DSIP, Selank, and Kisspeptin based on molecular size, brain access, pharmacokinetics, and the published literature.

May 5, 2026

Can I Still Buy Compounded Tirzepatide? (2026 Research Context)

FDA restricted compounded tirzepatide for human use when the shortage ended. The Research Use Only research peptide channel for tirzepatide (GLP-2 TZ) operates under entirely separate regulations.

May 5, 2026

For Research Use Only. MOTS-c is intended strictly for in vitro and preclinical animal research. It is not approved for human use, is not a drug, and should never be administered to humans.

Cardiac Mitochondrial Biology

The heart is a highly metabolically active organ that depends on oxidative phosphorylation for almost all of its ATP production. Cardiomyocytes are packed with mitochondria that occupy approximately thirty percent of the cell volume. The high mitochondrial content reflects the continuous energy demand of cardiac contraction, which cannot be interrupted without immediate functional consequences.

The high mitochondrial density makes cardiac tissue particularly sensitive to mitochondrial dysfunction. Ischemic injury, metabolic stress, and aging all affect cardiac mitochondria, and the compromised mitochondrial function translates directly to cardiac functional impairment. Interventions that support mitochondrial function therefore have logical cardioprotective potential.

MOTS-c research in cardiac contexts builds on the established mitochondrial biology documented in the MOTS-c AMPK pathway article. The AMPK activation, mitochondrial biogenesis support, and metabolic substrate utilization effects all apply to cardiac tissue as they do to skeletal muscle, liver, and other metabolically active tissues.

The Nature subject hub on cardiac mitochondria and the ScienceDirect cardiac mitochondrial biology topic page archive primary research on cardiac mitochondrial biology.

Ischemia Reperfusion Research

Ischemia reperfusion injury models using coronary artery ligation produce defined cardiac injury that recapitulates the pathology of myocardial infarction. Published MOTS-c research in these models documents reduced infarct size, preserved cardiac function, and improved outcomes in treated animals compared to vehicle controls.

The cardioprotective effects in ischemia reperfusion reflect the mitochondrial support that MOTS-c provides under conditions of severe metabolic stress. The ischemic phase depletes cellular ATP and triggers mitochondrial dysfunction. The reperfusion phase produces oxidative damage as the restored oxygen supply interacts with the compromised mitochondrial systems. MOTS-c support of mitochondrial function during both phases reduces the injury that accumulates.

The mechanisms implicated in the cardioprotective effects include preserved mitochondrial membrane potential during ischemia, reduced mitochondrial permeability transition pore opening during reperfusion, reduced reactive oxygen species production, and faster recovery of oxidative phosphorylation capacity after reperfusion. The combined effects preserve cardiomyocyte viability and cardiac function.

The ischemia reperfusion research connects to the BPC-157 cytoprotection article which covers cardioprotection from a different pharmacological perspective, and to the VIP cardiovascular article which covers coronary vasodilation through VPAC receptor signaling.

The Cell Press journal Cell Reports Medicine archives primary research on cardioprotection mechanisms.

Metabolic Cardiomyopathy Research

Diabetic cardiomyopathy and obesity induced cardiac dysfunction are research contexts where mitochondrial pathology plays a major role. Published MOTS-c research in diabetic and obese rodent models documents preserved cardiac function compared to untreated controls, with the protective effects associated with improved cardiac mitochondrial function.

The metabolic cardiomyopathy research connects MOTS-c to the broader metabolic peptide research documented across the Midwest Peptide catalog. The GLP-3 RT cardiovascular article covers triple agonist cardiac effects. The cagrilintide cardiovascular article covers amylin analog cardiac effects. Different compounds address metabolic cardiomyopathy through different primary mechanisms, and the mitochondrial approach of MOTS-c is complementary to the receptor mediated approaches of the other compounds.

The Wiley Online Library cardiovascular collection archives primary research on metabolic cardiomyopathy.

Aging Cardiac Function

Cardiac function declines with age through multiple mechanisms including mitochondrial dysfunction, reduced antioxidant capacity, altered calcium handling, and progressive fibrosis. Published MOTS-c research in aged rodent models documents partial preservation of cardiac function compared to untreated aged controls. The aging cardiac protection aligns with the broader MOTS-c aging research documented in the aging article.

The aging cardiac research connects to the NAD+ in Research: A Comprehensive Review of Nicotinamide Adenine Dinucleotide Studies because both NAD+ and MOTS-c address mitochondrial aging biology through complementary pathways. The two compounds represent complementary research tools for investigating cardiac aging in preclinical models.

Heart Failure Model Research

Heart failure models including pressure overload from aortic constriction and volume overload from arteriovenous fistula have been used to examine MOTS-c effects on heart failure progression. Published research documents attenuated cardiac hypertrophy, reduced fibrosis, and preserved systolic function in treated animals compared to controls.

The heart failure protection operates through the mitochondrial biology that is central to MOTS-c pharmacology. Failing hearts have impaired mitochondrial function that contributes to the progressive decline in contractile capacity. MOTS-c support of mitochondrial function addresses this central pathological feature and attenuates the functional decline.

The heart failure research connects to the GHK-Cu anti-fibrotic article through the shared interest in cardiac fibrosis reduction. Different compounds address cardiac fibrosis through different mechanisms.

Doxorubicin Cardiotoxicity

Doxorubicin cardiotoxicity is a well characterized research context where mitochondrial dysfunction is central to the pathology. Published MOTS-c research in doxorubicin cardiotoxicity models documents preserved cardiac function and reduced histological damage in treated animals. The cardioprotection aligns with the broader cytoprotection biology of mitochondrial supportive compounds in chemotherapy induced organ injury contexts.

The doxorubicin research connects to the broader chemotherapy cardiotoxicity research and to the BPC-157 cytoprotection article which covers cytoprotection in various organ injury contexts including drug induced injury.

Cardiac Metabolism Under Treatment

Cardiac metabolic flexibility allows the heart to use multiple substrates including fatty acids, glucose, ketones, and lactate for energy. The metabolic balance shifts under different physiological conditions, and pathological states are associated with reduced metabolic flexibility. Published MOTS-c research on cardiac metabolism documents improved metabolic flexibility with maintained capacity for fatty acid oxidation and appropriate shifts between substrate utilization patterns.

The metabolic flexibility findings complement the direct cardiac function data by providing mechanistic explanation for the preserved function. A heart with preserved metabolic flexibility can respond appropriately to changing demands, while a heart with restricted metabolic capacity is vulnerable to functional failure under stress.

The metabolic research connects to the MOTS-c insulin sensitivity article which covers glucose uptake in skeletal muscle through the same AMPK pathway biology that operates in the heart. The cardiac metabolic effects extend the skeletal muscle findings into the cardiac context.

The Frontiers in Cardiovascular Medicine open access journal archives primary research on cardiac metabolism.

Mitochondrial Quality Control

Mitochondrial quality control involves the integrated processes of mitochondrial biogenesis, mitophagy, and mitochondrial dynamics that maintain the mitochondrial network in functional condition. Dysfunctional mitochondria are cleared by mitophagy and replaced by newly generated mitochondria through biogenesis. Published MOTS-c research documents enhanced mitochondrial quality control in cardiac tissue including increased biogenesis markers, enhanced mitophagy capacity, and maintained mitochondrial network morphology.

The quality control findings provide mechanistic depth on the cardioprotective effects. The heart cannot tolerate accumulation of dysfunctional mitochondria because the high energy demand requires that the mitochondrial network remain in optimal functional condition. Enhanced quality control keeps the cardiac mitochondrial network functional under pathological stress.

Research Peptide Referenced

MOTS-c 10mg, research grade mitochondrial derived peptide, third party COA

For complete sourcing details see the MOTS-c sourcing guide.

Within the MOTS-c cluster:

Related clusters:

Not for human consumption. Research use only.

Explore more peer-reviewed research and laboratory guides from our science team:

All products are third-party tested with a Certificate of Analysis (COA) included. For research use only.

MOTS-C 10mg, 99%+ purity, COA included
NAD+ 500mg, 99%+ purity, COA included
VIP 10mg, 99%+ purity, COA included
GHK-Cu 50mg, 99%+ purity, COA included
Cagrilintide 10mg, 99%+ purity, COA included

Browse All Research Peptides →

Age Verification

MOTS-c Cardioprotection Research: Heart Injury Models

Frequently Asked Questions

What is MOTS-c in research contexts?

How does MOTS-c affect cardiac mitochondrial function in research?

What cardiac models are used in MOTS-c cardioprotection research?

Is MOTS-c approved for human use?

Glossary

More from the Blog

Subcutaneous vs Intranasal: Choosing an Administration Route for DSIP, Selank, and Kisspeptin in Research

Can I Still Buy Compounded Tirzepatide? (2026 Research Context)

Cardiac Mitochondrial Biology

Ischemia Reperfusion Research

Metabolic Cardiomyopathy Research

Aging Cardiac Function

Heart Failure Model Research

Doxorubicin Cardiotoxicity

Cardiac Metabolism Under Treatment

Mitochondrial Quality Control

Research Peptide Referenced

Ready to Start Your Research?

Where can researchers source third-party tested MOTS-c?

What's the Cheapest Way to Get Tirzepatide (GLP-2 TZ) for Research?

Age Verification

MOTS-c Cardioprotection Research: Heart Injury Models

Frequently Asked Questions

What is MOTS-c in research contexts?

How does MOTS-c affect cardiac mitochondrial function in research?

What cardiac models are used in MOTS-c cardioprotection research?

Is MOTS-c approved for human use?

Glossary

More from the Blog

Subcutaneous vs Intranasal: Choosing an Administration Route for DSIP, Selank, and Kisspeptin in Research

Can I Still Buy Compounded Tirzepatide? (2026 Research Context)

Cardiac Mitochondrial Biology

Ischemia Reperfusion Research

Metabolic Cardiomyopathy Research

Aging Cardiac Function

Heart Failure Model Research

Doxorubicin Cardiotoxicity

Cardiac Metabolism Under Treatment

Mitochondrial Quality Control

Research Peptide Referenced

Related Research Reading

Related Research Articles

Explore Related Products

Ready to Start Your Research?

Where can researchers source third-party tested MOTS-c?

What's the Cheapest Way to Get Tirzepatide (GLP-2 TZ) for Research?